Cardinal Health, Inc. (NYSE:CAH)’s market-beating performance reflects a business that has changed direction and executed ...
Zacks Investment Research on MSN
Here's how VKTX's obesity drug is moving quickly through phase III
Viking Therapeutics VKTX is one of the few companies with a late-stage obesity candidate in its pipeline. The company is ...
There’s good news in 2026 for seniors enrolled in Medicare Part D who rely on the priciest prescription drugs: 10 high-cost ...
Roivant Sciences Ltd. (NASDAQ:ROIV) is a clinical-stage biopharmaceutical company that discovers, develops, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback